Browsing Category
Health
Protection Secretary Austin is ‘actively concerned and engaged’ whereas hospitalized
US Secretary of Defense Lloyd J. Austin testifies before a House Armed Services Committee hearing on the conclusion of military operations in Afghanistan at…
Walgreens and three different health-care shares are going into our Bullpen watch listing
We're making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to…
CVS to shut ‘choose’ pharmacies in Goal shops within the coming months
CVS Health plans to close select pharmacies inside Target stores early this year, a company spokesperson said Thursday, as retail pharmacy chains in the U.S.…
YouTube launches First Support Info Cabinets to assist in emergencies
People walk past a billboard advertisement for YouTube in Berlin, Germany, on Sept. 27, 2019.Sean Gallup | Getty ImagesYouTube is taking steps to fight…
J&J to amass Ambrx Biopharma, a most cancers drug developer, for $2B
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019.Mark Ralston | AFP | Getty ImagesJohnson &…
Moderna Covid vaccine gross sales plunge in 2023, however meet firm forecast
Nikos Pekiaridis | Lightrocket | Getty ImagesModerna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer…
Eli Lilly weight reduction drug web site might not upend trade
Sopa Images | Lightrocket | Getty ImagesEli Lilly is shaking up the pharmaceutical industry with a new website offering telehealth prescriptions and direct…
Walgreens (WBA) earnings Q1 2024
Shares of Walgreens closed 5% lower on Thursday after the company reported fiscal first-quarter adjusted earnings and revenue that topped expectations, but…
Medicare drug worth negotiations what’s forward in 2024
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in…
Weight problems and Alzheimer’s medicine pack one-two punch to elevate Eli Lilly
Investor optimism for Eli Lilly 's diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should…